Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 6, 1997, Pages 2715-2718

  Ni, Y G ^a,b   Camacho, N ^a   Miledi, R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Channels; HeLa cells; Receptor binding; Xenopus oocytes

Indexed keywords

2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; SEROTONIN; SEROTONIN 1C RECEPTOR; SEROTONIN ANTAGONIST; TRITIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; HELA CELL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RNA TRANSCRIPTION; RNA TRANSLATION; SEROTONINERGIC SYSTEM; TEMPERATURE SENSITIVITY; XENOPUS;

ANIMALS; CEREBRAL CORTEX; FEMALE; HELA CELLS; HUMANS; KINETICS; MEMBRANE POTENTIALS; OOCYTES; POTASSIUM CHANNELS; QUINOLINES; RATS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RECOMBINANT PROTEINS; SEROTONIN; SEROTONIN ANTAGONISTS; TRANSFECTION; XENOPUS LAEVIS;

ANIMALIA; TRITIUM;

EID: 0030938096     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.6.2715     Document Type: Article

References (29)

1. Wilkinson, L. O. & Dourish, C. T. (1991) in Serotonin Receptor Subtypes: Basic and Clinical Aspects, ed. Peroutka, S. J. (Wiley-Liss, New York), pp. 147-210.
2. Conn, P. J., Sanders, B. E., Hoffman, B. J. & Hartig, P. R. (1986) Proc. Natl. Acad. Sci. USA 83, 4086-4088.
3. Kaufman, M. J., Hartig, P. R. & Hoffman, B. J. (1995) J. Neurochem. 64, 199-205.
4. Julius, D., MacDermott, A. B., Axel, R. & Jessell, T. M. (1988) Science 241, 558-564.
5. Miledi, R., Parker, I. & Sumikawa, K. (1989) in Fidia Research Foundation Neuroscience Award Lectures Series, ed. Smith, J. (Raven, New York), pp. 57-90.
6. Panicker, M. M., Parker, I. & Miledi, R. (1991) Proc. Natl. Acad. Sci. USA 88, 2560-2562.
7. Aiyar, J., Grissmer, S. & Chandy, K. G. (1993) Am. J. Physiol. 265, C1571-1578.
8. Meller, E., Bohmaker, K., Goldstein, M. & Friedhoff, A. J. (1985) J. Pharmacol. Exp. Ther. 233, 656-662.
9. Battaglia, G., Norman, A. B., Newton, P. L. & Creese, I. (1986) J. Neurochem. 46, 589-593.
10. Meller, E., Goldstein, M. & Bohmaker, K. (1990) Mol. Pharmacol. 37, 231-237.
11. Adham, N., Borden, L. A., Sehechter, L. E., Gustafson, E. L., Cochran, T. L., Vaysse, P. J., Weinshank, R. L. & Branchek, T. A. (1993) Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 566-575.
12. Adham, N., Ellerbrock, B., Hartig, P., Weinshank, R. L. & Branchek, T. (1993) Mol. Pharmacol. 43, 427-433.
13. Kusano, K., Miledi, R. & Stinnakre, J. (1982) J. Physiol. (London) 328, 143-170.
14. Miledi, R. (1982) Proc. R. Soc. London Ser. B 215, 491-497.
15. Miledi, R. & Woodward, R. M. (1989) J. Physiol. (London) 416, 601-621.
16. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254.
17. Woodward, R. M. & Miledi, R. (1991) Proc. R. Soc. London Ser. B 244, 11-19.
18. Tigyi, G., Dyer, D., Matute, C. & Miledi, R. (1990) Proc. Natl. Acad. Sci. USA 87, 1521-1525.
19. Belleau, B., DiTullio, V. & Godin, D. (1969) Biochem. Pharmacol. 18, 1039-1044.
20. Norman, A. B. & Creese, I. (1986) Mol. Pharmacol. 30, 96-103.
21. Hess, E. J., Battaglia, G., Norman, A. B. & Creese, I. (1987) Mol. Pharmacol. 31, 50-57.
22. Kathmann, M., Schlicker, E., Detzner, M. & Timmerman, H. (1993) Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 498-503.
23. Gozlan, H., Laporte, A. M., Thibault, S., Schechter, L. E., Bolanos, F. & Hamon, M. (1994) Neuropharmacology 33, 423-431.
24. Miledi, R. & Parker, I. (1984) J. Physiol. (London) 357, 173-183.
25. Oron, Y., Dascal, N., Nadler, E. & Lupu, M. (1985) J. Biol. Chem. 260, 7410-7421.
26. Parker, I. & Miledi, R. (1987) Proc. R. Soc. London Ser. B 231, 27-36.
27. Salles, J., Wallace, M. A. & Fain, J. N. (1993) Mol. Brain Res. 20, 111-117.
28. Boess, F. G. & Martin, I. L. (1994) Neuropharmacology 33, 275-317.
29. Pinto, W. & Battaglia, G. (1993) NeuroReport 5, 61-64.